CLINICAL PROBLEMS
Tóm tắt
Từ khóa
Tài liệu tham khảo
Akesson, 1994, Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide, Arthritis Rheum, 37, 729, 10.1002/art.1780370518
Alpert, 1991, Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome, and mixed connective tissue disease, Am J Cardiol, 68, 1687, 10.1016/0002-9149(91)90330-N
Al-Sabbagh, 1989, Pulmonary arterial histology and morphometry in systemic sclerosis: A case-control autopsy study, J Rheumatol, 16, 1038
Altman, 1991, Predictors of survival in systemic sclerosis (scleroderma), Arthritis Rheum, 34, 403, 10.1002/art.1780340405
Baron, 1982, (a) Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma, Br Heart J, 48, 304, 10.1136/hrt.48.3.304
Baron, 1982, (b) Prostaglandin E1 therapy for digital ulcers in scleroderma, Can Med Assoc J, 126, 42
Barst, 1996, A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension, N Engl J Med, 334, 296, 10.1056/NEJM199602013340504
Barst, 1994, Survival in primary hypertension with long-term continuous intravenous prostacyclin, Ann Intern Med, 121, 409, 10.7326/0003-4819-121-6-199409150-00003
Bolster MB, Ludwicka A, Strange C, et al. Cytokines in bronchoalveolar lavage (BAL) fluid of patients with systemic sclerosis (SSc) [abstract 622]. Abstracts of Scientific Presentations, 58th National Scientific Meeting of American College of Rheumatology, Minneapolis, October 23–27, 1994, p S263.
Bolster, 1993, Systemic sclerosis, 79
Broekelmann, 1991, Transforming growth factor-β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis, Proc Natl Acad Sci USA, 88, 6642, 10.1073/pnas.88.15.6642
Cambrey, 1994, Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro, Am J Respir Cell Mol Biol, 11, 439, 10.1165/ajrcmb.11.4.7917311
Chanez, 1993, Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung, Am Rev Respir Dis, 147, 1497, 10.1164/ajrccm/147.6_Pt_1.1497
Cordier, 1983, Pneumopathies interstitielles fibrosantes. Activite´ collage´nolytique du liquide alve´olaire, Presse Med, 12, 1345
D'Angelo, 1969, Pathologic observations in systemic sclerosis (scleroderma): A study of 58 autopsy cases and 58 matched controls, Am J Med, 46, 428, 10.1016/0002-9343(69)90044-8
de la Mata, 1994, Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases, Arthritis Rheum, 37, 1528, 10.1002/art.1780371018
Desmouliere, 1993, Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts, J Cell Biol, 122, 103, 10.1083/jcb.122.1.103
Emmanuel, 1976, Session 11: Acute and chronic fibrotic states: Environmental factors and the diffusing capacity of the lung in progressive systemic sclerosis, Chest, 69, 304, 10.1378/chest.69.2.304
Enson, 1975, Pulmonary hypertension in interstitial lung disease: Relation of vascular resistance to abnormal lung structure, Transactions of the Association of American Physicians, 88, 248
Fineman, 1995, Inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn, Acta Paediatr Jpn, 37, 425, 10.1111/j.1442-200X.1995.tb03350.x
Fritzler, 1980, The CREST syndrome: A distinct serologic entity with anticentromere antibodies, Am J Med, 69, 520, 10.1016/0002-9343(80)90462-3
Giaid, 1995, Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension, N Engl J Med, 333, 214, 10.1056/NEJM199507273330403
Giri, 1993, Effect of antibody to transforming growth factor-β on bleomycin-induced accumulation of lung collagen in mice, Thorax, 48, 959, 10.1136/thx.48.10.959
Harrison, 1989, Pulmonary involvement in systemic sclerosis: The detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance, Respir Med, 83, 403, 10.1016/S0954-6111(89)80072-1
Harrison, 1990, Evidence of protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosis, Thorax, 45, 606, 10.1136/thx.45.8.606
Harrison, 1991, Structural features of interstitial lung disease in systemic sclerosis, Am Rev Respir Dis, 144, 706, 10.1164/ajrccm/144.3_Pt_1.706
Hunninghake, 1979, Inflammatory and immune processes in the human lung in health and disease: Evaluation by bronchoalveolar lavage, Am J Pathol, 97, 149
Jansen, 1984, Local immune complexes and inflammatory response in patients with chronic interstitial pulmonary disorders associated with collagen vascular diseases, Clin Exp Immunol, 56, 311
Jordana, 1993, Cytokines in lung and airways fibrosis, Reg Immunol, 5, 201
Khalil, 1989, Macrophage production of transforming growth factor-β and fibroblast collagen synthesis in chronic pulmonary fibrosis, J Exp Med, 170, 727, 10.1084/jem.170.3.727
Khalil, 1996, TGF-β1, but not TGF-β2 or TGF-β3, is differentially present in epithelial cells of advanced pulmonary fibrosis: An immunohistochemical study, Am J Respir Cell Mol Biol, 14, 131, 10.1165/ajrcmb.14.2.8630262
Khalil, 1991, Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis, Am J Respir Cell Mol Biol, 5, 155, 10.1165/ajrcmb/5.2.155
Khalil, 1993, Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat, J Clin Invest, 92, 1812, 10.1172/JCI116771
Kinsella, 1989, Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma, Arthritis Rheum, 32, 577, 10.1002/anr.1780320511
Kouyoumdijan, 1994, Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats, J Clin Invest, 94, 578, 10.1172/JCI117372
Lawrence, 1980, Increased bronchoalveolar IgG-secreting cells in interstitial lung diseases, N Engl J Med, 302, 1186, 10.1056/NEJM198005223022106
Lee, 1992, Mortality in systemic sclerosis (scleroderma), Q J Med (New Series 82), 298, 139
Levine, 1994, Single lung transplantation in patients with systemic disease, Chest, 105, 837, 10.1378/chest.105.3.837
Ludwicka, 1995, Elevated levels of TGF-β1 and PDGF in scleroderma bronchoalveolar lavage fluid, J Rheumatol, 22, 1876
Ludwicka, 1992, Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of scleroderma patients, J Rheumatol, 19, 1716
Lynch, 1992, Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8, Am Rev Respir Dis, 145, 1433, 10.1164/ajrccm/145.6.1433
Martinet, 1987, Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis, N Engl J Med, 317, 202, 10.1056/NEJM198707233170404
Martinot, 1989, Clinical and subclinical alveolitis in collagen vascular diseases: Contribution of α-2 macroglobulin level in BAL fluid, Eur Respir J, 2, 437, 10.1183/09031936.93.02050437
Matucci-Cerinic, 1990, Clinical correlations of plasma angiotensin converting enzyme (ACE) activity in systemic sclerosis: A longitudinal study of plasma ACE level, endothelial injury, and lung involvement, Respir Med, 84, 283, 10.1016/S0954-6111(08)80054-6
Mitchell, 1989, Alpha-smooth muscle actin in parenchymal cells of bleomycin-injured rat lung, Lab Invest, 60, 643
Miyazaki, 1995, Expression of a tumor necrosis factor-α transgene in murine lung causes lymphocytic and fibrosing alveolitis, J Clin Invest, 96, 250, 10.1172/JCI118029
Moreland, 1992, Transforming growth factor-β within fibrotic scleroderma lungs, Am J Med, 93, 628, 10.1016/0002-9343(92)90195-H
Morgan, 1991, Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension, Chest, 99, 551, 10.1378/chest.99.3.551
Odekon, 1994, Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β, J Cell Physiol, 158, 398, 10.1002/jcp.1041580303
Ohar, 1985, The role of vasodilators in patients with progressive systemic sclerosis: Interstitial lung disease and pulmonary hypertension, Chest, 88, 263S
Ohba, 1994, Scleroderma BAL fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of the PDGF α receptor, Am J Resp Cell Mol Biol, 10, 405, 10.1165/ajrcmb.10.4.7510986
Ohta, 1995, Immunohistochemical identification and characterization of smooth muscle-like cells in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med, 152, 1659, 10.1164/ajrccm.152.5.7582311
Owens, 1986, Role of inflammation in the lung disease of systemic sclerosis: Comparison with idiopathic pulmonary fibrosis, J Lab Clin Med, 107, 253
Piguet, 1990, Requirement of TNF for development of silica-induced pulmonary fibrosis, Nature, 344, 245, 10.1038/344245a0
Piguet, 1989, TNF plays a key role in bleomycin-induced pneumopathy and fibrosis, J Exp Med, 170, 655, 10.1084/jem.170.3.655
Read, 1960, Acute diffuse interstitial pulmonary fibrosis in scleroderma, Aust Ann Med, 9, 271
Remy-Jardin, 1993, Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: Pathologic-CT correlation, Radiology, 189, 693, 10.1148/radiology.189.3.8234692
Reynolds, 1977, Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis, J Clin Invest, 59, 165, 10.1172/JCI108615
Rossi, 1985, Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis, Am Rev Respir Dis, 131, 612, 10.1164/arrd.1985.131.4.612
Salerni, 1977, Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma), Ann Intern Med, 86, 394, 10.7326/0003-4819-86-4-394
Sappino, 1990, Smooth muscle differentiation in scleroderma fibroblastic cells, Am J Pathol, 137, 585
Seibold, 1987, Acute hemodynamic effects of ketanserin in pulmonary hypertension secondary to systemic sclerosis, J Rheumatol, 14, 519
Sfikakis, 1991, Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril, Am J Med, 90, 541, 10.1016/0002-9343(91)90627-A
Sibille, 1990, Phagocyte enzymes in bronchoalveolar lavage from patients with pulmonary sarcoidosis and collagen vascular disorders, Eur Respir J, 3, 249, 10.1183/09031936.93.03030249
Silver, 1986, Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid, Arthritis Rheum, 29, 525, 10.1002/art.1780290410
Silver, 1984, Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage, Arthritis Rheum, 27, 1254, 10.1002/art.1780271107
Silver, 1990, Evaluation and management of scleroderma lung disease using bronchoalveolar lavage, Am J Med, 88, 470, 10.1016/0002-9343(90)90425-D
Silver, 1993, Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease, J Rheumatol, 20, 838
Sitbon, 1995, Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin, Am J Respir Crit Care Med, 151, 384, 10.1164/ajrccm.151.2.7842196
Smith, 1979, Echocardiographic features of progressive systemic sclerosis (PSS): Correlation with hemodynamic and postmortem studies, Am J Med, 66, 28, 10.1016/0002-9343(79)90478-9
Southcott, 1993, T-cell receptor Vα gene usage is not restricted in scleroderma-associated pulmonary fibrosis, Arthritis Rheum, 36, S270
Southcott, 1993, Interleukin-8 is associated with the presence of pulmonary fibrosis in systemic sclerosis, Arthritis Rheum, 36, S181
Standiford, 1993, Interleukin-8: A major mediator of acute pulmonary inflammation, Reg Immunol, 5, 134
Standiford, 1993, Macrophage inflammatory protein-1 α expression in interstitial lung disease, J Immunol, 151, 2852, 10.4049/jimmunol.151.5.2852
Steen, 1990, Natural history of severe pulmonary fibrosis in systemic sclerosis (SSc), Arthritis Rheum, 33, S157
Steen, 1992, Isolated diffusing capacity reduction in systemic sclerosis, Arthritis Rheum, 35, 765, 10.1002/art.1780350709
Steen, 1994, Therapy for severe interstitial lung disease in systemic sclerosis, Arthritis Rheum, 37, 1290, 10.1002/art.1780370904
Steen, 1988, Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis, Arthritis Rheum, 31, 196, 10.1002/art.1780310207
Stupi, 1986, Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis, Arthritis Rheum, 29, 515, 10.1002/art.1780290409
Sullivan, 1984, A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease, Medicine, 63, 92, 10.1097/00005792-198403000-00003
Thornton, 1992, Fibroblast growth factors in connective tissue disease–associated interstitial lung disease, Clin Exp Immunol, 90, 447, 10.1111/j.1365-2249.1992.tb05866.x
Ungerer, 1983, Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis, Am J Med, 75, 65, 10.1016/0002-9343(83)91169-5
Vancheeswaran, 1994, Circulating endothelin-1 levels in systemic sclerosis subsets—A marker of fibrosis or vascular dysfunction?, J Rheumatol, 21, 1838
Wallaert, 1988, Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases, Thorax, 43, 24, 10.1136/thx.43.1.24
Wallaert, 1986, Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function, Am Rev Respir Dis, 133, 574
Wangensteen, 1983, Bleomycin-induced changes in pulmonary microvascular albumin permeability and extravascular albumin space, Am Rev Respir Dis, 127, 204
Warrick, 1991, High-resolution computed tomography in early scleroderma lung disease, J Rheumatol, 18, 1520
Wells, 1993, Serial CT in fibrosing alveolitis: Prognostic significance of the initial pattern, AJR Am J Roentgenol, 161, 1159, 10.2214/ajr.161.6.8249719
Wise, 1982, The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon, Chest, 81, 695, 10.1378/chest.81.6.695
Young, 1978, Pulmonary vascular changes in scleroderma, Am J Med, 64, 998, 10.1016/0002-9343(78)90455-2
Yousem, 1990, The pulmonary pathologic manifestations of the CREST syndrome, Hum Pathol, 21, 467, 10.1016/0046-8177(90)90002-M
Yurovsky, 1995, The repertoire of T-cell receptors in systemic sclerosis, Crit Rev Immunol, 15, 155, 10.1615/CritRevImmunol.v15.i2.30
Zhang, 1995, Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis, Am J Pathol, 147, 352